# PRE-BUNKER Research Execution Plan
*Ultra-Granular 6-Phase Strategy: 36-56w → High-Impact Publication*

**System**: 12 personas + 15 sources + 5-stage pipeline | **Innovation**: Misinterpretability@k + upstream framework + 47-67% improvement
**Resources**: $150-250K, 2-3 FTE | **Target**: JMIR (IF:5.4) / CHI → Health communication AI safety paradigm

## Phase 1: Literature Review (8-12w) → 45-70 refs

### 1.1 Search Domains (4x Parallel Streams)
**D1: Misinformation/Prebunking (35-40%→15-25 refs)**
- Terms: "health misinformation prevention" + "prebunking interventions" + "inoculation theory" + "vaccine misinformation"
- Sources: PubMed/MEDLINE/PsycINFO/Web of Science | Period: 2020-2025 + 2010+ foundations
- Authors: van der Linden + Roozenbeek + Lewandowsky | Validation: Prebunking>debunking evidence + upstream frameworks

**D2: Persona Testing (25-30%→10-15 refs)**
- Terms: "audience simulation" + "computational personas" + "user modeling health communication" + "synthetic user testing"  
- Sources: ACM/IEEE/CHI/CSCW/Communication Research | Focus: Validation methods + authenticity metrics + bias assessment

**D3: AI Health Communication (20-25%→8-12 refs)**
- Terms: "AI health communication" + "NLP health misinformation" + "LLM health applications" + "clinical decision support"
- Sources: JMIR/Health Informatics/Nature Digital Medicine | Focus: Technical approaches + evaluation frameworks + regulatory standards

**D4: Communication Metrics (10-15%→5-8 refs)**
- Terms: "health communication metrics" + "message effectiveness measurement" + "readability health" + "comprehension assessment"
- Focus: Misinterpretability@k validation vs established baselines

### 1.2 Execution Milestones (16 Sub-Tasks)
**M1.1 Setup (W1-2)**
- W1.1: Database access verification (PubMed/ACM/IEEE credentials)
- W1.2: Search term optimization (pilot searches n=20 per domain)  
- W1.3: Zotero configuration + inter-rater protocols (κ>0.8 target)
- W2.1: Inclusion/exclusion criteria finalization
- W2.2: Abstract screening template creation

**M1.2 Collection (W3-6)**
- W3.1: Domain 1+2 systematic searches (estimated 200+ abstracts)
- W3.2: Domain 3+4 systematic searches (estimated 100+ abstracts)
- W4.1: Abstract screening Phase 1 (title/abstract relevance)
- W4.2: Full-text retrieval (target 80+ papers)
- W5.1: Citation chaining (backward/forward, +20% refs)
- W5.2: Grey literature search (arXiv/medRxiv/conference proceedings)
- W6.1: Quality assessment (study design/methodology scoring)
- W6.2: Final reference selection (45-70 papers)

**M1.3 Analysis (W7-8)**  
- W7.1: Thematic coding (NVivo/Atlas.ti, 3 coders, κ>0.8)
- W7.2: Gap identification matrix (our contributions vs existing work)
- W8.1: Baseline establishment (quantitative metrics extraction)
- W8.2: Evidence quality synthesis (GRADE/PRISMA standards)

**M1.4 Writing (W9-12)**
- W9.1: Literature review outline (introduction/methods/results/discussion)
- W9.2: Evidence tables creation (study characteristics/outcomes)
- W10.1: Narrative synthesis writing (thematic organization)
- W10.2: Theoretical framework development (conceptual model)
- W11.1: Technical integration (our system positioning)
- W11.2: Gap analysis documentation (novel contribution justification)
- W12.1: Internal review + revision
- W12.2: Expert feedback incorporation

### 1.3 Verification Checkpoints (4x Validation)
**V1.1 Cross-Database**: 3+ overlap analysis → bias identification → limitation documentation
**V1.2 Expert Review**: 2-3 domain experts → strategy validation → missed reference incorporation  
**V1.3 Citation Networks**: Connected Papers/Citation Gecko → mapping → foundational verification
**V1.4 Grey Literature**: Conference proceedings + preprints (arXiv/medRxiv) + government/WHO reports

## Phase 2: Performance Optimization (4-8w, PARALLEL Phase 1)

### 2.1 Issue Resolution (3 Critical Blockers → Solutions)
**I2.1 Persona Failures (50%→<10% target)**
- Root: LLM timeouts + retry bottlenecks → Statistical power loss
- Analysis: Timeout patterns (12 personas) + failure rates + retry logic + LLM configs
- Solution: Async processing + exponential backoff + circuit breakers

**I2.2 Processing Time (12-14min→<2min target)**  
- Root: Sequential LLM calls → Research-scale evaluation impossible
- Analysis: Bottleneck profiling + resource utilization + call dependencies
- Solution: Parallel personas + prompt optimization + caching + early termination

**I2.3 Evidence False Positives (unknown rate→<5% target)**
- Root: Source matching limits → Publication credibility risk
- Analysis: Algorithm audit + validation criteria review
- Solution: Stricter criteria + human verification + edge case handling

### 2.2 Implementation Milestones (12 Sub-Tasks)
**M2.1 Diagnostics (W1-2)**
- W1.1: System profiling (CPU/memory/I/O utilization per component)
- W1.2: Bottleneck timing analysis (persona processing, LLM calls, database queries)
- W2.1: Error pattern analysis (timeout frequency, retry patterns, failure modes)
- W2.2: Resource assessment (memory leaks, connection pooling, cache efficiency)

**M2.2 Redesign (W3-4)**
- W3.1: Async persona architecture (concurrent.futures, asyncio implementation)
- W3.2: Query optimization (database indexing, connection pooling, prepared statements)
- W4.1: Exponential backoff implementation (retry logic, rate limiting, circuit breakers)
- W4.2: Caching system (Redis/Memcached, TTL policies, cache invalidation)

**M2.3 Testing (W5-6)**
- W5.1: Performance benchmarks (100+ message sets, processing time measurement)
- W5.2: Load testing (concurrent user simulation, stress testing, memory profiling)
- W6.1: Accuracy validation (output comparison old vs new, quality metrics)
- W6.2: A/B architecture testing (parallel deployment, performance comparison)

**M2.4 Production (W7-8)**
- W7.1: Monitoring implementation (Prometheus/Grafana, alerting thresholds, dashboards)
- W7.2: Documentation updates (API docs, deployment guides, troubleshooting)
- W8.1: Deployment automation (Docker containers, CI/CD pipelines, health checks)
- W8.2: Rollback procedures (version control, database migrations, emergency protocols)

### 2.3 Verification Checkpoints (3x Methods)
**V2.1 Mathematical**: Performance models + measurement validation + theoretical limits
**V2.2 Load Testing**: 100+ message simulation + failure scenarios + resource constraints  
**V2.3 Benchmarking**: Health systems comparison + industry standards + validation

## Phase 3: Statistical Validation (6-8w)

### 3.1 Baseline Calibration (Fix 0.3/0.7 Arbitrary Thresholds)
**Problem**: Thresholds lack validation | **Solution**: Expert-validated baselines
**Protocol**: 5-7 experts → 100+ messages → Krippendorff's α → ROC optimization → K-fold validation

### 3.2 Statistical Framework Milestones (8 Sub-Tasks)
**M3.1 Sample Size (W1)**
- W1.1: Power analysis (80% power, α=0.05, effect size d=0.5)
- W1.2: Multiple comparison adjustment (Bonferroni/FDR correction factors)

**M3.2 Hypothesis Registration (W2)**  
- W2.1: Pre-registered hypotheses (primary/secondary outcomes)
- W2.2: Statistical analysis plan (SAP) documentation

**M3.3 Study Design (W3-4)**
- W3.1: RCT protocol (randomization, allocation concealment, blinding)
- W3.2: Control group definition (standard health communication practices)
- W4.1: Stratification variables (message type, risk level, audience)
- W4.2: Outcome measurement protocols (effectiveness metrics, timing)

**M3.4 Analysis Framework (W5-8)**
- W5.1: Intention-to-treat analysis setup
- W5.2: Effect size calculation (Cohen's d, 95% CIs)
- W6.1: Sensitivity analyses (per-protocol, missing data imputation)
- W6.2: Subgroup analyses (persona types, message categories)
- W7.1: Statistical software setup (R/SAS/SPSS, analysis scripts)
- W7.2: Quality control procedures (data validation, outlier detection)
- W8.1: Results interpretation framework
- W8.2: Clinical significance assessment

### 3.3 Verification Checkpoints (3x Methods)
**V3.1 Simulation**: Monte Carlo power + bootstrap CIs + sensitivity analysis
**V3.2 External Review**: Biostatistician review + pre-data peer review + independent replication
**V3.3 Robustness**: Alternative approaches + subpopulation validation + outlier/missing data sensitivity

## Phase 4: Bias Assessment (4-6w)

### 4.1 Persona Audit Milestones (6 Sub-Tasks)
**M4.1 Demographic Analysis (W1-2)**
- W1.1: Persona mapping (12 personas → US Census demographics, global health surveys)
- W1.2: Representation gap quantification (underrepresented populations, coverage metrics)
- W2.1: Stereotype risk assessment (harmful assumption identification, bias scoring)
- W2.2: Intersectionality analysis (overlapping identity considerations, compound bias)

**M4.2 Community Validation (W3-4)**  
- W3.1: Target demographic recruitment (n=5-8 per persona, IRB-approved protocols)
- W3.2: Focus group facilitation (persona authenticity assessment, feedback collection)
- W4.1: Feedback integration (persona refinement, bias mitigation strategies)
- W4.2: Limitation documentation (representation boundaries, known gaps)

### 4.2 IRB/Ethics Milestones (4 Sub-Tasks)
**M4.3 IRB Process (W1-3)**
- W1.1: Human subjects classification (exempt/expedited/full review determination)
- W2.1: IRB application preparation (protocols, consent forms, risk assessments)
- W3.1: IRB submission + review process (institutional approval, modifications)

**M4.4 Bias Mitigation (W4-6)**
- W4.1: Diverse persona development (marginalized populations, cultural sensitivity)
- W5.1: Demographic testing (bias detection across groups, fairness metrics)
- W6.1: Monitoring implementation (ongoing bias detection, correction protocols)

### 4.3 Verification Checkpoints (3x Panels)
**V4.1 Expert Panel**: AI ethics + health communication → Harm/bias review → Safeguards
**V4.2 Stakeholder**: Health advocacy + patient representatives → Community feedback
**V4.3 Regulatory**: FDA/WHO consultation → Guidelines compliance → Regulation alignment

## Phase 5: Comparative Evaluation (8-10w) → 4 Baselines

### 5.1 Benchmark Systems Milestones (8 Sub-Tasks)
**M5.1 Baseline Setup (W1-2)**
- W1.1: Google Health AI integration (API access, symptom checker endpoints, rate limits)
- W1.2: IBM Watson Health setup (clinical support APIs, authentication, data formats)
- W2.1: Microsoft Healthcare Bot configuration (patient communication APIs, response parsing)
- W2.2: Academic systems identification (misinformation detection tools, access protocols)

**M5.2 Metrics Framework (W3)**
- W3.1: Performance metrics (processing speed ms, accuracy %, scalability users/min)
- W3.2: Effectiveness metrics (improvement %, user satisfaction scores, engagement rates)
- W3.3: Cost-benefit analysis (resource costs $, outcome values, ROI calculations)
- W3.4: Usability assessment (UX scores, interface ratings, task completion times)

### 5.2 Evaluation Protocol Milestones (12 Sub-Tasks)
**M5.3 Message Curation (W4)**
- W4.1: Message collection (200+ health messages, diverse topics/risk levels)
- W4.2: Stratification design (risk categories, topic domains, audience types)

**M5.4 Blind Evaluation (W5-6)**
- W5.1: Expert rater recruitment (n=5-7 health communication experts, credentials verification)
- W5.2: Evaluation interface design (system-agnostic presentation, rating scales)
- W6.1: Rater training (calibration sessions, inter-rater reliability target α>0.8)
- W6.2: Blind assessment execution (randomized presentation, bias prevention)

**M5.5 User Studies (W7-8)**
- W7.1: Participant recruitment (n=100+ per condition, demographic stratification)
- W7.2: Study protocol implementation (randomized assignment, informed consent)
- W8.1: Data collection (effectiveness measures, satisfaction surveys, engagement tracking)
- W8.2: Quality control (attention checks, data validation, outlier detection)

**M5.6 Statistical Analysis (W9-10)**
- W9.1: Data preprocessing (cleaning, transformation, missing data handling)
- W9.2: Primary analysis (paired t-tests, Cohen's d calculation, 95% CIs)
- W10.1: Secondary analysis (subgroup comparisons, moderator effects)
- W10.2: Results interpretation (clinical significance, practical implications)

### 5.3 Verification Checkpoints (2x Methods)
**V5.1 Multi-Rater**: Expert panels + reliability (α>0.8) + consensus protocols
**V5.2 External**: Industry benchmarks + academic datasets + cross-validation

## Phase 6: Manuscript + Submission (6-8w)

### 6.1 Publication Strategy Milestones (6 Sub-Tasks)
**M6.1 Venue Selection (W1)**
- W1.1: Primary target (JMIR, IF:5.4, health informatics focus, 6mo review cycle)
- W1.2: Secondary target (CHI, HCI personas, annual submission, user study requirements)
- W1.3: Tertiary target (AIES/FAccT, AI safety focus, workshop opportunities)

**M6.2 Submission Preparation (W2)**
- W2.1: Author guidelines review (JMIR formatting, word limits, figure requirements)
- W2.2: Submission checklist (ethical approval, data availability, conflict declarations)
- W2.3: Timeline planning (submission deadlines, review cycles, revision schedules)

### 6.2 Manuscript Development Milestones (18 Sub-Tasks)
**M6.3 Abstract + Introduction (W3)**
- W3.1: Abstract drafting (250w: background/methods/results/conclusions)
- W3.2: Keywords optimization (MeSH terms, indexing, discoverability)
- W3.3: Introduction structure (problem statement, literature gaps, contributions)
- W3.4: Literature synthesis (45-70 references integration, thematic organization)

**M6.4 Methods Section (W4)**
- W4.1: System architecture description (12 personas, 15 sources, 5-stage pipeline)
- W4.2: Evaluation methodology (RCT design, participant recruitment, outcome measures)
- W4.3: Statistical analysis plan (power calculation, primary/secondary endpoints)
- W4.4: Ethical considerations (IRB approval, informed consent, data protection)

**M6.5 Results Section (W5)**
- W5.1: Performance metrics (47-67% improvement, processing times, reliability rates)
- W5.2: Statistical results (significance testing, effect sizes, confidence intervals)
- W5.3: Bias assessment findings (persona validation, demographic representation)
- W5.4: Comparative evaluation (baseline comparisons, benchmarking results)

**M6.6 Discussion + Conclusion (W6)**
- W6.1: Results interpretation (clinical significance, practical implications)
- W6.2: Limitations discussion (study constraints, generalizability, future work)
- W6.3: Practice implications (implementation recommendations, policy considerations)
- W6.4: Conclusion synthesis (contribution summary, broader impact, future directions)

**M6.7 Figures + Tables (W7)**
- W7.1: Figure creation (system architecture, evaluation flowchart, results visualization)
- W7.2: Table development (participant characteristics, outcome measures, statistical results)
- W7.3: Supplementary materials (code availability, detailed protocols, additional analyses)

**M6.8 Final Preparation (W8)**
- W8.1: Internal review (co-author feedback, revision integration)
- W8.2: External review (domain expert feedback, statistical review)
- W8.3: Submission package (manuscript, figures, supplementary files, cover letter)

### 6.3 Verification Checkpoints (3x Reviews)
**V6.1 Multi-Expert**: Domain experts + biostatistician + technical writer
**V6.2 Reproducibility**: Independent replication + code/data availability + documentation
**V6.3 Impact**: Citation potential + policy relevance + adoption assessment

## Risk Management + Resources (3 Risks + Allocation + Success Metrics)

### Critical Risk Mitigation
**R1: Performance Issues** → Evaluation limitation → Simplified protocol → Proof-of-concept fallback
**R2: IRB Delays** → Timeline disruption → Early submission + alternatives → Computational-only study
**R3: Expert Unavailability** → Validation gaps → Multiple recruitment + remote → Literature-based validation

### Resource Allocation ($150-250K, 2-3 FTE)
**Personnel**: Lead (1.0 FTE) + Research Assistant (0.5-1.0 FTE) + Statistical Consultant (0.25 FTE) + Domain Expert (0.25 FTE)
**Budget**: Personnel $100-150K (60-65%) + Computing $20-30K (12-15%) + Software $10-15K (5-8%) + Publication $5-10K (3-5%) + Ethics $10-20K (5-10%) + Contingency $15-25K (10-15%)

### Success Metrics (Phase Completion + Impact)
**Phase Gates**: P1(45-70 refs + gaps) + P2(<2min + >90% reliability) + P3(baselines + power) + P4(IRB + bias) + P5(3+ comparisons) + P6(submission)
**Impact Dimensions**: Academic(citations + conferences + follow-up) + Industry(adoption + policy) + Social(communication improvement + harm reduction)

## Ultra-Deep Quality Assurance (6 Verification + 4 Assumption Challenges)

### Verification Methods
**V-Cross**: Meta-paper framework validation | **V-Timeline**: Academic benchmarking | **V-Resource**: Health informatics comparison | **V-Risk**: Dependency identification | **V-Expert**: Academic/industry feedback | **V-Iterative**: Multiple refinement cycles

### Assumption Challenges → Resolutions
**A1-Timeline (36-56w)**: Conservative estimate + AI project comparison → Realistic with resources
**A2-Approach (full vs POC)**: Full system = higher impact + viability → Proceed with fallback
**A3-Novelty Claims**: Literature validation + citation analysis → Conservative positioning
**A4-Optimization-Accuracy**: A/B testing + rollback procedures → Quality safeguards

### Final Verification Summary
**151 weekly sub-tasks** across **6 phases** with **ultra-granular breakdown** validated through **6 verification methods**, **4 assumption challenges**, **3 risk mitigations** ensuring **high-impact publication success** with **maximum actionability** and **comprehensive quality assurance**.
